The 3rd International Online Conference on Cells: Charming Micro-Insights into Health and Diseases
The 3rd International Online Conference on Cells: Charming Micro-Insights into Health and Diseases
Part of the International Online Conference on Cells series
Event's Timezone: Central European Time
15th December 2024
24th January 2025
5th February 2025
11th February 2025
20th March 2025
Cellular Signalling, Cancer Treatment, Senescence Aging, Neurodegeneration, Development, Cellular Immunology
Welcome from the Chair
Conference Chair,
University of Minnesota, USA
Event Chair
Prof. Dr. Alexander E. Kalyuzyhny received his B.S. and M.S. from the Department of Biochemistry and Biophysics at the Saratov State University (Russia) in 1981. He investigated the mechanisms underlying the pre-implantation development of mouse embryos. Between 1983 and 1988, he investigated the effects of narcotic substances on early morphogenesis, receiving his Ph.D. in 1988. In 1992, Dr. Kalyuzhny moved to the USA to join the Department of Pharmacology at the University of Minnesota Medical School. Later, he joined the Department of Neuroscience at the university where he was then affiliated as a Research Assistant Professor. His academic research interests are focused on the mechanisms underlying the functions of opioid receptors. Since 1998, Dr. Kalyuzhny has been involved in both teaching and editorial work.
Session Chairs
Prof. Dr. Srinivasan Madhusudan
Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK
Srinivasan Madhusudan is the Professor of Medical Oncology and Director of Naaz-Coker Ovarian cancer Research Centre at the Biodiscovery Institute, School of Medicine, University of Nottingham. His clinical expertise is in the management of Ovarian and Breast Cancers. His pre-clinical laboratory is focussed on translational DNA damage signalling and repair in cancers.
Prof. Dr. George Smith
1. Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, USA 2. Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, USA
After graduating with a BS in Chemistry Dr. Smith moved to Case Western Reserve University and completed his graduate studies in the Department of Developmental Genetic and Neurosciences under the mentorship of Dr. J Silver. During this time, he worked on the changing role of astrocytes from growth promoting (immature) to scar forming (mature). He also coauthored 3 patents, leading to the formation of the Biotech company, Gliatech, Inc. with Dr. Silver. After graduation, Dr. Smith moved to Baylor College of Medicine for postdoctoral studies, where he examined the roles of neurotrophins in regeneration. In 1991, he started his first laboratory at UT Southwestern Medical Center as an Assistant Professor studying the role of neurotrophins in regeneration of sensory afferents into the spinal cord. He also became interested in and joined the BME program developing filamentous nerve growth conduits. We were the first groups to examine the use of bioresorbable filaments to guide axons across the conduit. This research led to authorship on numerous manuscripts and 3 patents. In 2001, Dr. Smith was recruited as an Associate Professor to the Spinal cord and Brain Injury Research Center (SCoBIRC) at the University of Kentucky continuing his work on neurotrophins in spinal cord injury and Parkinson’s disease. Where he furthered his work constructing and producing various recombinant virus systems to examine regeneration and targeting of transplanted neurons. In 2011, Dr. Smith moved to Philadelphia to study pediatric spinal cord injury. There he changed his research direction from neurotrophins to motor control. He is presently Professor and Vice Chair of the Department of Neural Sciences and Director of the Center for Neural Development and Repair. The primary goal of his laboratory is to enhance axon regeneration and circuit reformation of the spinal cord after injury or in neurodegenerative disorders, with the long-term goal of developing and transferring treatments to human patients.
Prof. Dr. Santhi Gorantla
College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
Dr. Susanta K. Behura
Division of Animal Sciences, University of Missouri, Columbia, MO, USA
Prof. Dr. Roger Schneiter
Department of Biology, University of Fribourg, Fribourg, Switzerland
Roger Schneiter is a Professor of Biochemistry at the Department of Biology of the University of Fribourg, Switzerland. His laboratory is focused on the characterization of molecular mechanisms of lipid droplet biogenesis in the unicellular model eukaryote baker's yeast and the characterization of CAP superfamily proteins in plants and fungal phytopathogens.
Prof. Dr. Fulvio Mario Reggiori
Department of Biomedicine, Aarhus University, Aarhus, Denmark
Dr. Mohammad Asim
Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7WG, UK
Dr. Mohammad Asim is a Cancer Molecular Biologist who studies molecular mechanisms that drive prostate cancer progression in order to find novel and more effective treatments. His research has primarily focussed on understanding the role of the androgen receptor signalling in prostate cancer and how it is activated in cancer leading to drug resistance. Mohammad graduated with a PhD from Justus Liebig University for his work uncovering the role of signal transduction pathways and transcriptional corepressors in regulating androgen receptor signalling in prostate cancer. Following a postdoc in Cancer therapeutics at the University of Wisconsin, where he discovered novel anti-androgens, he took up a Senior Scientist position at the Cancer Research UK Cambridge Institute at the University of Cambridge. Here, Mohammad's ground-breaking work identified the first-ever mammalian kinase that can act as a chaperone for the androgen receptor and is a drug target. At Surrey, his work uncovered a novel synthetic lethal relationship between the androgen receptor and Poly (ADP-Ribose) Polymerase pathway which is being clinically exploited to treat castration-resistant prostate cancer (CRPC). His lab identified PDZ binding Kinase as a mediator of androgen receptor function in CRPC thus revealing the molecular mechanism underlying the failure of hormone therapy for prostate cancer. This work contributed to understanding pathways that can cause the failure of hormone/radiation therapy and can thus be exploited in developing combination approaches for effective cancer treatment. For his discoveries on a novel dual-activity anti-androgenic drug currently in development, Dr Asim was awarded a Young Investigator Award from the Prostate Cancer Foundation. In addition to his role at Surrey, Dr Asim concurrently holds a visiting scientist post at the University of Cambridge.
Event Committees
Valrose Biology Institute, Côte d'Azur University, Nice, France
The Society for the Investigation of Early Pregnancy (SIEP), New York, USA
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Arthur A. Dugoni School of Dentistry, University of the Pacific, USA
Radiation Physiology Laboratory, Singapore Nuclear Research and Safety Initiative, National University of Singapore, Singapore
138602, Singapore
Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai 480-0392, Japan
Keynote Speaker
The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, School of Medicine, The Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel
Invited Speaker
Department of Biomedical, Dental Sciences and Morphofunctional Images, University of Messina, Messina, Italy
Sessions
SESSION B. Neural Cell Biology
SESSION C. Cellular Antivirus Immune Responses
SESSION D. Cell Therapies
SESSION E. Cellular Signaling
SESSION F. Cell Research in Animal Models
SESSION G. Cellular Metabolism
SESSION H. Protein Quality Control, Proteasomal Degradation and Autophagy
Registration
When registering as an "Academic", please register with your academic email address, as this will accelerate the registration process. If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for understanding.
Participation to the conference is considered final only once the registration fees have been paid. The number of participants is limited: once the number of paid registrations reaches the maximum number of participants, unpaid registrations will be cancelled.
Please note that, in order to finalize the scientific program in due time, at least one registration by any of the authors, denoted as the “Covering Author”, is required to cover the presentation and publication of any accepted abstract. The “Covering Author” registration deadline is 11 February 2025. Your abstract will be withdrawn if your registration is not completed by this date.
Finally, only registered authors will be able to apply for the Conference Awards.
|
Early Bird Until 5th February 2025 |
Regular Until 20th March 2025 |
Supported documents | |
|---|---|---|---|
| Author, Reviewers, Topical Advisory Panel Members, Review Board Members, Guest Editors | 30.00 CHF | 50.00 CHF | |
| Student | 30.00 CHF | 50.00 CHF |
Please upload the front and back of your valid Student lD card. |
| Academic | 40.00 CHF | 60.00 CHF | |
| Non-Academic | 100.00 CHF | 150.00 CHF | |
| Chairs, Invited Speakers, Committee Members of the Conference, MDPI Guests, Editorial Board Members | Free | Free |
Cancellation policy
| > 2 weeks before the conference | Full refund |
| < 2 weeks before the conference | No refund |
Disclaimer
We will endeavour to present the program advertised. However, MDPI and its partners reserve the right to alter or cancel, without prior notice, arrangements, timetables, plans, or other items relating directly or indirectly to The 3rd International Online Conference on Cells: Charming Micro-Insights into Health and Diseases. MDPI and its partners are not liable for any loss or inconvenience caused as a result of such cancellation.
Beware of Unauthorized Registration
Note that Sciforum is the only official registration platform to register to CELLS 2025. Beware that entering into financial agreements with non-endorsed companies can have costly consequences.
Insurance
The organizers do not accept liability for personal accident, loss, or damage to private property incurred as a result of participation in the event.
Payment methods
Wire transfer, Credit card
Currencies accepted by this event
Swiss francs (CHF) , Euros (EUR) , US dollars (USD) and Singapore dollars (SGD)
Instructions for Authors
The 3rd International Online Conference on Cells: Charming Micro-Insights into Health and Diseases will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
1. Deadline for abstract submission: 15 December 2024.
2. Announcement of oral and poster abstract results: 24 January 2025. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract submissions should be completed online by registering with www.sciforum.net and using the "New Submission" function once logged into the system. No physical template is necessary.
1. The structure abstract should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All accepted abstracts will be published in the conference report of cells2025 in MDPI’s Biology and Life Sciences Forum journal (ISSN: 2673-9976) after quality check. If you wish to publish a research article in the journal, please refer to the “Publication Opportunities” Section.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
a. Your submission should include the title, authors, contact details, and main research findings, as well as tables, figures, and graphs where necessary.
b. File format: PDF (.pdf).
c. Size in cm: 60 width x 80 height–portrait orientation.
d. Font size: ≥20.
e. Maximum size: 250 M
You can use our free template to create your poster. The poster template can be downloaded here.
The Poster Sessions will take place in Zoom break-out rooms. The rooms will be called after your surname. You will automatically be assigned to your break-out room, however, you will be responsible for your own room, i.e. sharing your screen by yourself, handling the comments in the chat if there are any, etc. People will then be able to visit your room and discuss your poster with you. Please make sure you have the Zoom Desktop client or mobile app, version 5.3.0 or higher.
We will reach out to you closer to the dates of the conference with more information.
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
1. Cells Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue "Charming Micro-Insights into Health and Diseases", published in Cells ( ISSN: 2073-4409, Impact Factor 5.1), with a 10% discount on the publication fee. Details of the special issue will be announced here later. Please note that no other discounts are applicable. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Manuscripts for the proceedings issue must be formatted as follows:
-
Title.
-
Full author names.
-
Affiliations (including full postal address) and authors' e-mail addresses.
-
Abstract.
-
Keywords.
-
Introduction.
-
Methods.
-
Results and Discussion.
-
Conclusions.
-
Acknowledgements.
-
References.
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 3 awards including Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 3
The Best Oral Presentation Award is given to the submission judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be three winners selected for these awards. The winner will receive a certificate and 200 CHF each.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Dorothy Cai
Ms. Katrina Zhang
